Cardiac PI3K-Akt impairs insulin-stimulated glucose uptake independent of mTORC1 and GLUT4 translocation

Molecular Endocrinology

Volumn 27, Issue 1, 2013, Pages 172-184

  Zhu, Yi ^a   Pereira, Renata O ^a   O'Neill, Brian T ^a,e   Riehle, Christian ^a   Ilkun, Olesya ^a   Wende, Adam R ^a   Rawlings, Tenley A ^a   Zhang, Yi Cheng ^a   Zhang, Quanjiang ^a   Klip, Amira ^a,b   Shiojima, Ichiro ^a,c   Walsh, Kenneth ^a,d   Dale Abel, E ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RIBOSOME PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOLEMMA; TRANSGENE; WILD TYPE;

ANIMALS; CELLS, CULTURED; DEOXYGLUCOSE; ENZYME ACTIVATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HEXOKINASE; INSULIN; MICE; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIROLIMUS;

ANIMALIA; MUS; MUS MUSCULUS; PROTEA;

EID: 84871749894     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1210     Document Type: Article

References (37)

1. Chang L, Chiang SH, Saltiel AR 2004 Insulin signaling and the regulation of glucose transport. Mol Med 10:65-71
2. Hubbard SR 1997 Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J 16:5572-5581
3. Czech MP 2003 Dynamics of phosphoinositides in membrane retrieval and insertion. Annu Rev Physiol 65:791-815
4. Cantley LC 2002 The phosphoinositide 3-kinase pathway. Science 296:1655-1657
5. Abel ED 2004 Glucose transport in the heart. Front Biosci 9:201-215
6. Hoffman NJ, Elmendorf JS 2011 Signaling, cytoskeletal and membrane mechanisms regulating GLUT4 exocytosis. Trends Endocrinol Metab 22:110-116
7. Ishikura S, Koshkina A, Klip A 2008 Small G proteins in insulin action: Rab and Rho families at the crossroads of signal transduction and GLUT4 vesicle traffic. Acta Physiol 192:61-74
8. Chen XW, Leto D, Chiang SH, Wang Q, SaltielAR2007 Activation of RalA is required for insulin-stimulated Glut4 trafficking to the plasma membrane via the exocyst and the motor protein Myo1c. Dev Cell 13:391-404
9. Ueda S, Kitazawa S, Ishida K, Nishikawa Y, Matsui M, Matsumoto H, Aoki T, Nozaki S, Takeda T, Tamori Y, Aiba A, Kahn CR, Kataoka T, Satoh T 2010 Crucial role of the small GTPase Rac1 in insulin-stimulated translocation of glucose transporter 4 to the mouse skeletal muscle sarcolemma. FASEB J 24:2254-2261
10. Hodgkinson CP, Mander A, Sale GJ2005 Protein kinase-f interacts with munc18c: role in GLUT4 trafficking. Diabetologia 48:1627-1636
11. Contreras-Ferrat AE, Toro B, Bravo R, Parra V, Vásquez C, Ibarra C, Mears D, Chiong M, Jaimovich E, Klip A, Lavandero S 2010 An inositol 1,4,5-triphosphate (IP3)-IP3 receptor pathway is required for insulin-stimulated glucose transporter 4 translocation and glucose uptake in cardiomyocytes. Endocrinology 151:4665-4677
12. Bryant NJ, Govers R, James DE 2002 Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 3:267-277
13. Pirola L, Bonnafous S, Johnston AM, Chaussade C, Portis F, Van Obberghen E 2003 Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells. J Biol Chem 278:15641-15651
14. Shah OJ, Wang Z, Hunter T 2004 Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 14:1650-1656
15. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas G 2004 Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431:200-205
16. Feuvray D, Darmellah A 2008 Diabetes-related metabolic perturbations in cardiac myocyte. Diabetes Metab 34(Suppl 1):S3-S9
17. Cook SA, Varela-Carver A, Mongillo M, Kleinert C, Khan MT, Leccisotti L, Strickland N, Matsui T, Das S, Rosenzweig A, Punjabi P, Camici PG 2010 Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. Eur Heart J 31:100-111
18. Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, Izumo S 2000 The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19:2537-2548
19. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K 2005 Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115:2108-2118
20. Kanai F, Nishioka Y, Hayashi H, Kamohara S, Todaka M, Ebina Y 1993 Direct demonstration of insulin-induced GLUT4 translocation to the surface of intact cells by insertion of a c-myc epitope into an exofacial GLUT4 domain. J Biol Chem 268:14523-14526
21. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, Abel ED 2002 Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 109:629-639
22. Mandarino LJ, Printz RL, Cusi KA, Kinchington P, O'Doherty RM, Osawa H, Sewell C, Consoli A, Granner DK, DeFronzo RA 1995 Regulation of hexokinase II and glycogen synthase mRNA, protein, and activity in human muscle. Am J Physiol 269:E701-E708
23. O'Doherty RM, Bracy DP, Osawa H, Wasserman DH, Granner DK 1994 Rat skeletal muscle hexokinase II mRNA and activity are increased by a single bout of acute exercise. Am J Physiol 266: E171-E178
24. Grossbard L, Schimke RT 1966 Multiple hexokinases of rat tissues. Purification and comparison of soluble forms. J Biol Chem 241: 3546-3560
25. Bricker DK, Taylor EB, Schell JC, Orsak T, Boutron A, Chen YC, Cox JE, Cardon CM, Van Vranken JG, Dephoure N, Redin C, Boudina S, Gygi SP, Brivet M, Thummel CS, Rutter J 2012 A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 337:96-100
26. Gossen M, Bujard H 1992 Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551
27. Agha-Mohammadi S, O'Malley M, Etemad A, Wang Z, Xiao X, Lotze MT 2004 Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness. J Gene Med 6:817-828
28. Tremblay F, Brûlé S, HeeUm S, Li Y, Masuda K, Roden M, Sun XJ, Krebs M, Polakiewicz RD, Thomas G, Marette A 2007 Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci USA 104:14056-14061
29. Kohn AD, Summers SA, Birnbaum MJ, Roth RA 1996 Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271:31372-31378
30. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM 2005 Phosphor-ylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098-1101
31. Somwar R, Koterski S, Sweeney G, Sciotti R, Djuric S, Berg C, Trevillyan J, Scherer PE, Rondinone CM, Klip A 2002 A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adi-pocytes without affecting GLUT4 translocation. J Biol Chem 277: 50386-50395
32. Hoehn KL, Hohnen-Behrens C, Cederberg A, Wu LE, Turner N, Yuasa T, Ebina Y, James DE 2008 IRS1-independent defects define major nodes of insulin resistance. Cell Metab 7:421-433
33. Wright JJ, Kim J, Buchanan J, Boudina S, Sena S, Bakirtzi K, Ilkun O, Theobald HA, Cooksey RC, Kandror KV, Abel ED 2009 Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding. Cardiovasc Res 82:351-360
34. Antonescu CN, Huang C, Niu W, Liu Z Eyers PA, Heidenreich KA, Bilan PJ, Klip A 2005 Reduction of insulin-stimulated glucose uptake in L6 myotubes by the protein kinase inhibitor SB203580 is independentof p38MAPK activity. Endocrinology 146:3773-3781
35. Foley K, Boguslavsky S, Klip A 2011 Endocytosis, recycling, and regulated exocytosis of glucose transporter 4. Biochemistry 50: 3048-3061
36. Sweeney G, Garg RR, Ceddia RB, Li D, Ishiki M, Somwar R, Foster LJ, Neilsen PO, Prestwich GD, Rudich A, Klip A 2004 Intracellular delivery of phosphatidylinositol (3,4,5)-trisphosphate causes incorporation of glucose transporter 4 into the plasma membrane of muscle and fat cells without increasing glucose uptake. J Biol Chem 279:32233-32242
37. Stenkula KG, Lizunov VA, Cushman SW, Zimmerberg J 2010 Insulin controls the spatial distribution of GLUT4 on the cell surface through regulation of its postfusion dispersal. Cell Metab 12:250- 259